In this video, we dive deep into GLP-1 medications like Semaglutide (Ozempic, Wegovy) and Liraglutide (Victoza, Saxenda), exploring their impact on weight loss, cardiovascular health, and longevity. Discover how these groundbreaking drugs go beyond treating diabetes to help reduce inflammation, protect against heart disease, and promote long-term health. We’ll review key clinical trials, including LEADER, SUSTAIN-6, and STEP, to uncover the evidence behind GLP-1’s potential to enhance lifespan. Whether you're interested in obesity treatment or looking to understand how GLP-1 drugs can improve overall health, this video is for you.

Keywords:
GLP-1 medications, Semaglutide, Liraglutide, weight loss, cardiovascular health, longevity, anti-aging, diabetes, obesity, SUSTAIN trial, LEADER trial, STEP trial, Ozempic, Wegovy, Victoza, Saxenda, GLP-1 and heart health, inflammation reduction, anti-inflammatory, chronic disease prevention, healthy aging, GLP-1 receptor agonists, metabolic health, diabetes medication longevity, life extension

свернуть